ResMed Aktie
215,80
EUR
-1,40
EUR
-0,64
%
244,44
USD
-1,25
USD
-0,51
%
Werbung
ResMed Aktie Analyse
25.09.17 | ResMed Underweight | Barclays Capital | |
07.04.16 | ResMed Underweight | Barclays Capital | |
27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung